Sign in
Taking people in United StatesNo phase

The Effects of Stellate Ganglion Block Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for PTSD

Key facts

Who runs it
The University of Texas Health Science Center at San Antonio
Where
Killeen and San Antonio, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
40 people, planned
Started
15 Jun 2026
Expected to end
30 Jun 2027
Type of study
Observational, 2 groups
Treatments tested
  • Sleep Profiler Headband
Record updated
6 October 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Ability to provide informed consent and follow study-related instructions
  • Be randomized into the study titled "Combining Stellate Ganglion Block with Prolonged Exposure for PTSD: A Randomized Clinical Trial." NCT05889741
  • Indicates willingness to wear the Sleep Profiler sleep monitor and to complete self-report assessments

Who cannot take part

  • Pre-existing skin or soft tissue condition that precludes the ability to wear the Sleep Profiler headband

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Carl R. Darnall Army Medical Center at Fort HoodKilleen, United StatesContact: Jennifer D Hein, MDTaking people
  • University of Texas Health Science Center at San AntonioSan Antonio, United StatesContact: Kristi Pruiksma, PhD, DBSMTaking people

About the trial

What the trial wants to find out

Participants in this study will have already been enrolled in another research study: Combining Stellate Ganglion Block with Prolonged Exposure for PTSD, NCT05889741. The investigators are using a Sleep Profiler, EEG headband to monitor a participants brainwaves while they sleep to see what effects the Stellate Ganglion Block injection has on their sleep. Participants will wear the headband for 3 nights before the injection and then 3 nights after the injection. Participants will also complete self-report questionnaires regarding their sleep prior to the injection and following the injection. Approximately 40 participants will be included in this study. This study is a nested observational study whereby participants in the parent study who elect to participate will have their sleep assessed using the EEG headband device and self-reported sleep measures performed.

The 2 groups in the trial

  • Massed Prolonged Exposure (PE) with SGB group

    Participants will wear the EEG headband monitoring device (Sleep Profiler)for 3 nights as a baseline prior to SGB injection administered as part of enrollment in original study from which they were recruited. After the SGB injection, participants will wear the headband monitoring device for 3 nights.

    Treatment: Sleep Profiler Headband

  • Massed PE Exposure with Sham SGB

    Participants will wear the EEG headband monitoring device (Sleep Profiler) for 3 nights as a baseline prior to the sham SGB injection administered as part of enrollment in original study from which they were recruited. Participants will wear the EEG headband monitoring device for 3 nights following the sham SGB injection.

    Treatment: Sleep Profiler Headband

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Stellate Ganglion Block on Sleep in U.S. Active Duty Service Members and Veterans Receiving Prolonged Exposure Therapy for Posttraumatic Stress Disorder (PTSD)
Criteria questions
Built from NCT07667309, who can take part
Record updated
6 October 2026